Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
24/02/202014h00Business WireTeva Announces FDA Approval of ArmonAir® Digihaler™ (fluticasone propionate) Inhalation PowderNYSE:TEVATeva Pharmaceutical Industries Ltd
19/02/202022h05Business WireTeva Announces Registration Trials of Deutetrabenazine in Pediatric Patients with Tourette Syndrome Did Not Meet the Primary ...NYSE:TEVATeva Pharmaceutical Industries Ltd
12/02/202013h30Business WireNew Report Shows Teva Generic Medicines Saved US Healthcare System $41.9 BillionNYSE:TEVATeva Pharmaceutical Industries Ltd
12/02/202013h00Business WireTeva Reports Fourth Quarter and Full Year 2019 Financial ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
06/02/202007h14Business Wireテバが日本でのAJOVY®(フレマネズマブ)の臨床試験の良好なトップライン結果を発表NYSE:TEVATeva Pharmaceutical Industries Ltd
03/02/202009h30Business WireTeva Announces Positive Top-Line Results from AJOVY® (fremanezumab) Clinical Trials in JapanNYSE:TEVATeva Pharmaceutical Industries Ltd
28/01/202023h16Dow Jones NewsTeva Says FDA Approves Ajovy AutoinjectorNYSE:TEVATeva Pharmaceutical Industries Ltd
28/01/202022h05Business WireTeva Announces FDA Approval of AJOVY® (fremanezumab-vfrm) Injection AutoinjectorNYSE:TEVATeva Pharmaceutical Industries Ltd
15/01/202023h00Business WireTeva to Host Conference Call to Discuss Fourth Quarter 2019 Financial Results & 2020 Financial Guidance at 8 a.m. ET on Febru...NYSE:TEVATeva Pharmaceutical Industries Ltd
10/01/202020h18Dow Jones NewsEndo Agrees to Pay $8.8 Million to Settle Oklahoma Opioid CaseNYSE:TEVATeva Pharmaceutical Industries Ltd
06/01/202023h22Business WireTeva to Present at the 38th Annual J.P. Morgan Healthcare ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
02/01/202022h26Dow Jones NewsDrug Prices Climb by 5.8% on Average, Less Than Last YearNYSE:TEVATeva Pharmaceutical Industries Ltd
16/12/201913h30GlobeNewswire Inc.NexImmune Appoints Sol Barer as Chairman of the Board of DirectorsNYSE:TEVATeva Pharmaceutical Industries Ltd
27/11/201909h02Dow Jones NewsOpioid Makers Hit With Criminal Probe -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
26/11/201919h51Dow Jones NewsOpioid Makers, Distributors Fall Following WSJ Report on Federal ProbeNYSE:TEVATeva Pharmaceutical Industries Ltd
26/11/201919h18Dow Jones NewsFederal Prosecutors Launch Criminal Probe of Opioid Makers, DistributorsNYSE:TEVATeva Pharmaceutical Industries Ltd
25/11/201914h00Business WireTeva Announces Early Tender Results of its Debt Tender Offer and Election of Early SettlementNYSE:TEVATeva Pharmaceutical Industries Ltd
19/11/201919h21Business WireTeva Announces Successful Upsize of Senior Notes Offering and Pricing of $2.1 Billion of Senior NotesNYSE:TEVATeva Pharmaceutical Industries Ltd
16/11/201909h02Dow Jones NewsJohnson & Johnson Opioid Verdict Cut -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
15/11/201923h15Dow Jones NewsJohnson & Johnson's Oklahoma Opioid Penalty Reduced to $465 MillionNYSE:TEVATeva Pharmaceutical Industries Ltd
08/11/201915h44Business WireTeva Announces $1.5 Billion Debt Tender OffersNYSE:TEVATeva Pharmaceutical Industries Ltd
08/11/201915h43Business WireTeva Announces Launch of $1,500,000,000 Offering of Senior NotesNYSE:TEVATeva Pharmaceutical Industries Ltd
07/11/201922h37Dow Jones NewsHigh Debt, Potential Litigation Costs Face New Teva CFONYSE:TEVATeva Pharmaceutical Industries Ltd
07/11/201913h15Business WireTeva & Celltrion Announce the Availability of TRUXIMA® (rituximab-abbs) Injection, the First Biosimilar to Rituxan® (rituxi...NYSE:TEVATeva Pharmaceutical Industries Ltd
07/11/201913h05Business WireTeva Announces Appointment of New Chief Financial OfficerNYSE:TEVATeva Pharmaceutical Industries Ltd
07/11/201913h00Business WireTeva Reports Third Quarter 2019 Financial ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
01/11/201923h00Business WireTeva to Host Conference Call to Discuss Third Quarter 2019 Financial Results at 8 a.m. ET on November 7, 2019 (Updated Dial-i...NYSE:TEVATeva Pharmaceutical Industries Ltd
31/10/201914h00PR Newswire (Canada)Teva Canada annonce le lancement des capsules [Pr]Teva-Fingolimod, une version générique bioéquivalente de [Pr]Gilenya®, ...NYSE:TEVATeva Pharmaceutical Industries Ltd
31/10/201913h54PR Newswire (Canada)Teva Canada Announces the Launch of a Bioequivalent Generic Version of [Pr]Gilenya®, [Pr]Teva-Fingolimod Capsules for the tr...NYSE:TEVATeva Pharmaceutical Industries Ltd
24/10/201914h00Business WireTeva to Present New Analyses of Fremanezumab and Country-Specific Burden of Migraine at 24th World Congress of NeurologyNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA